Literature DB >> 7729271

Clinical characteristics and natural history of symptomatic but not excess gastroesophageal reflux.

K C Trimble1, S Douglas, A Pryde, R C Heading.   

Abstract

Esophageal pH monitoring in patients with gastroesophageal reflux symptoms identifies some who have normal esophageal acid exposure but nevertheless a convincing correlation between symptoms and those reflux events that do occur. These patients may exhibit enhanced sensory perception of physiological reflux. Little is known about the natural history of reflux symptoms in this group, which in our experience comprises up to 6% of those referred for diagnostic pH monitoring. We have therefore followed up by postal questionnaire 70 patients whose initial pH study had demonstrated normal acid exposure but a symptom index > or = 50% and 58 patients found to have excess reflux, for a median of 4.4 and 6.5 years, respectively. The presenting character and frequency of symptoms and endoscopic and manometric findings were similar in the two groups. At review overall symptom frequency had improved (P < 0.01) for both groups similarly. However, 87% of those with normal acid exposure and 79% of those with excess reflux remained symptomatic, 53% and 47%, respectively, recording their symptoms to be the same or worse than at original presentation, despite over 60% in each group continuing to take regular medication. Only six patients in each group were asymptomatic and receiving no therapy at the time of review. The results demonstrate that patients with symptomatic but not excess gastroesophageal reflux constitute a significant clinical problem. Both the persistence of their symptoms and their requirement for therapy are similar to that observed in "genuine" refluxers.

Entities:  

Mesh:

Year:  1995        PMID: 7729271     DOI: 10.1007/bf02064206

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  20 in total

1.  Does the intraesophageal pH probe accurately detect acid reflux? Simultaneous recording with two pH probes in humans.

Authors:  D W Murphy; Y Yuan; D O Castell
Journal:  Dig Dis Sci       Date:  1989-05       Impact factor: 3.199

2.  The symptom index: a clinically important parameter of ambulatory 24-hour esophageal pH monitoring.

Authors:  G J Wiener; J E Richter; J B Copper; W C Wu; D O Castell
Journal:  Am J Gastroenterol       Date:  1988-04       Impact factor: 10.864

3.  Mechanism of gastroesophageal reflux in recumbent asymptomatic human subjects.

Authors:  J Dent; W J Dodds; R H Friedman; T Sekiguchi; W J Hogan; R C Arndorfer; D J Petrie
Journal:  J Clin Invest       Date:  1980-02       Impact factor: 14.808

4.  Ambulatory 24 hour intraesophageal pH-monitoring in the diagnosis of gastroesophageal reflux disease.

Authors:  F Johnsson; B Joelsson; P E Isberg
Journal:  Gut       Date:  1987-09       Impact factor: 23.059

Review 5.  Gastroesophageal reflux. Pathogenesis, diagnosis, and therapy.

Authors:  J E Richter; D O Castell
Journal:  Ann Intern Med       Date:  1982-07       Impact factor: 25.391

6.  Predictive factors of the long term outcome in gastro-oesophageal reflux disease: six year follow up of 107 patients.

Authors:  E Kuster; E Ros; V Toledo-Pimentel; A Pujol; J M Bordas; L Grande; C Pera
Journal:  Gut       Date:  1994-01       Impact factor: 23.059

7.  Three year follow up of patients with gastrooesophageal reflux disease.

Authors:  N E Schindlbeck; A G Klauser; G Berghammer; W Londong; S A Müller-Lissner
Journal:  Gut       Date:  1992-08       Impact factor: 23.059

8.  Symptom index as a marker of gastro-oesophageal reflux disease.

Authors:  B T Johnston; R J McFarland; J S Collins; A H Love
Journal:  Br J Surg       Date:  1992-10       Impact factor: 6.939

9.  Prospective manometric evaluation with pharmacologic provocation of patients with suspected esophageal motility dysfunction.

Authors:  S B Benjamin; J E Richter; C M Cordova; T E Knuff; D O Castell
Journal:  Gastroenterology       Date:  1983-05       Impact factor: 22.682

10.  Lowered oesophageal sensory thresholds in patients with symptomatic but not excess gastro-oesophageal reflux: evidence for a spectrum of visceral sensitivity in GORD.

Authors:  K C Trimble; A Pryde; R C Heading
Journal:  Gut       Date:  1995-07       Impact factor: 23.059

View more
  21 in total

1.  An evidence-based appraisal of reflux disease management--the Genval Workshop Report.

Authors: 
Journal:  Gut       Date:  1999-04       Impact factor: 23.059

2.  Esophageal histology does not provide additional useful information over clinical assessment in identifying reflux patients presenting for esophagogastroduodenoscopy.

Authors:  S Nandurkar; N J Talley; C J Martin; T Ng; S Adams
Journal:  Dig Dis Sci       Date:  2000-02       Impact factor: 3.199

Review 3.  Endoscopy-negative reflux disease.

Authors:  J P Galmiche; S B des Varannes
Journal:  Curr Gastroenterol Rep       Date:  2001-06

4.  Functional Gastroesophageal Reflux Disease (GERD).

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  2000-08

5.  Most GERD symptoms are not due to acid reflux in patients with very low 24-hour acid contact times.

Authors:  Bryan T Green; J Barry O'Connor
Journal:  Dig Dis Sci       Date:  2004-08       Impact factor: 3.199

Review 6.  Functional heartburn: definition and management strategies.

Authors:  Frank Zerbib; Stanislas Bruley des Varannes; Mireille Simon; Jean Paul Galmiche
Journal:  Curr Gastroenterol Rep       Date:  2012-06

7.  Double blind cross-over placebo controlled study of omeprazole in the treatment of patients with reflux symptoms and physiological levels of acid reflux--the "sensitive oesophagus".

Authors:  R G Watson; T C Tham; B T Johnston; N I McDougall
Journal:  Gut       Date:  1997-05       Impact factor: 23.059

8.  Hiatal hernia, lower esophageal sphincter incompetence, and effectiveness of Nissen fundoplication in the spectrum of gastroesophageal reflux disease.

Authors:  Reginald V N Lord; Steven R DeMeester; Jeffrey H Peters; Jeffrey A Hagen; Dino Elyssnia; Corinne T Sheth; Tom R DeMeester
Journal:  J Gastrointest Surg       Date:  2008-12-03       Impact factor: 3.452

9.  Reasons for participating in randomised controlled trials: conditional altruism and considerations for self.

Authors:  Sharon K McCann; Marion K Campbell; Vikki A Entwistle
Journal:  Trials       Date:  2010-03-22       Impact factor: 2.279

Review 10.  GORD in adults.

Authors:  Paul Moayyedi; Brendan Delaney
Journal:  BMJ Clin Evid       Date:  2008-06-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.